Home Life Sciences Level of non-conventional lipid parameters and its comparative analysis with TSH in subclinical hypothyroidism
Article
Licensed
Unlicensed Requires Authentication

Level of non-conventional lipid parameters and its comparative analysis with TSH in subclinical hypothyroidism

  • Sanjiv Kumar Bansal , Arpita Suri ORCID logo , Varsha Suryan EMAIL logo , Naveen Kumar Singh and Smita Barman
Published/Copyright: September 1, 2022

Abstract

Objectives

The objective of this study is to estimate lipid parameters in subclinical hypothyroidism and correlate it with TSH.

Methods

Forty newly diagnosed cases of subclinical hypothyroidism and Forty age and gender-matched healthy controls were recruited for the study. Blood samples were collected from them and serum lipid profile (i.e. HDL, LDL, TG, serum total cholesterol) of the subjects was estimated by standard photometric methods in a fully auto-analyzer (MINDRAY BS-300) using commercially available kits and VLDL cholesterol was calculated using the Friedewald’s formula. While serum Ox-LDL, Lipoprotein A, Apolipoprotein A1 and Apo B were estimated by using commercial kit based on enzyme-linked immmunosorbent assay.

Results

The parameters such as Oxidized low-density lipoprotein (Ox-LDL), lipoprotein (a), apolipoprotein A1, apolipoprotein B and small dense lipoprotein (sd LDL) were significantly increased in subclinical hypothyroid cases when compared with the control subjects (p<0.0001). In present study results showed significant positive correlations of serum thyroid stimulating hormone (TSH) with Ox-LDL (r=0.85, p<0.01), sd LDL (r=0.71, p<0.01).

Conclusions

The present study focuses on the role of Ox-LDL, sd-LDL Lipoprotein A, Apolipoprotein A1 and Apo B that are sensitive indicators of atherogenic dyslipidemia in subclinical hypothyroidism and can serve as a better & novel risk factor for CAD.


Corresponding author: Varsha Suryan, MSc, Department of Biochemistry, Faculty of Medicine & Health Sciences, SGT University, Gurugram, Haryana, India, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

References

1. Devdhar, M, Ousman, YH, Burman, KD. Hypothyroidism. Endocrinol Metab Clin N Am 2007;36:595–615. https://doi.org/10.1016/j.ecl.2007.04.008.Search in Google Scholar PubMed

2. Gaitonde, DY, Rowley, KD, Sweeney, LB. Hypothyroidism: an update. S Afr Fam Pract 2012;54:384–90. https://doi.org/10.1080/20786204.2012.10874256.Search in Google Scholar

3. Singer, PA. Thyroiditis. Acute, subacute, and chronic. Med Clin 1991;75:61–77. https://doi.org/10.1016/s0025-7125(16)30472-2.Search in Google Scholar PubMed

4. Dominguez, LJ, Bevilacqua, M, DiBella, G, Barbagallo, M. Diagnosing and managing thyroid disease in the nursing home. J Am Med Dir Assoc 2008;9:9–17. https://doi.org/10.1016/j.jamda.2007.07.011.Search in Google Scholar PubMed

5. Wiersinga, WM. Thyroid disease manager. Adult hypothyroidism. 2014. Available from: http://www.thyroidmanager.org/chapter/adult-hypothyroidism [Accessed 12 Jan 2012].Search in Google Scholar

6. Kostner, GM, Grillhofer, HK. Lipoprotein (a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts. J Biol Chem 1991;266:21287–92. https://doi.org/10.1016/s0021-9258(18)54853-5.Search in Google Scholar

7. Lippi, G, Guidi, G. Lipoprotein (a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 2003;40:1–42. https://doi.org/10.1080/713609328.Search in Google Scholar PubMed

8. Sniderman, AD, Furberg, CD, Keech, A, Van Lennep, JR, Frohlich, J, Jungner, I, et al.. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003;361:777–80. https://doi.org/10.1016/s0140-6736(03)12663-3.Search in Google Scholar PubMed

9. Benvenga, S, Cahnmann, HJ, Robbins, J. Localization of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins. Endocrinology 1990;127:2241–6. https://doi.org/10.1210/endo-127-5-2241.Search in Google Scholar PubMed

10. Azizi, F, Raiszadeh, F, Solati, MT, Etemadi, A, Rahmani, M, Arabi, M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest 2003;26:703–9. https://doi.org/10.1007/bf03347350.Search in Google Scholar

11. Raiszadeh, F, Solati, M, Etemadi, A, Azizi, F. Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clin Endocrinol 2004;60:75–80. https://doi.org/10.1111/j.1365-2265.2004.01940.x.Search in Google Scholar PubMed

12. Steinberg, D, Parthasarathy, S, Carew, TE, Khoo, JC, Witztum, JL. Beyond cholesterol. N Engl J Med 1989;320:915–24. https://doi.org/10.1056/NEJM198904063201407.Search in Google Scholar PubMed

13. Parthasarathy, S. Modified lipoproteins in the pathogenesis of atherosclerosis. Orlando: RG Landes Co; 1994.Search in Google Scholar

14. Trpkovic, A, Resanovic, I, Stanimirovic, J, Radak, D, Mousa, SA, Cenic-Milosevic, D, et al.. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci 2015;52:70–85. https://doi.org/10.3109/10408363.2014.992063.Search in Google Scholar PubMed

15. Fong, LG, Parthasarathy, S, Witztum, JL, Steinberg, D. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res 1987;28:1466–77. https://doi.org/10.1016/s0022-2275(20)38576-x.Search in Google Scholar

16. Kim, CS, Kang, JG, Lee, SJ, Ihm, SH, Yoo, HJ, Nam, JS, et al.. Relationship of low‐density lipoprotein (LDL) particle size to thyroid function status in Koreans. Clin Endocrinol 2009;71:130–6. https://doi.org/10.1111/j.1365-2265.2008.03436.x.Search in Google Scholar PubMed

17. Rizos, CV, Elisaf, MS, Liberopoulos, EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J 2011;5:76. https://doi.org/10.2174/1874192401105010076.Search in Google Scholar PubMed PubMed Central

18. Sundaram, V, Hanna, AN, Koneru, L, Newman, HA, Falko, JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metabol 1997;82:3421–4. https://doi.org/10.1210/jcem.82.10.4315.Search in Google Scholar PubMed

19. Rajappa, M, Sridhar, MG, Balachander, J, Sethuraman, KR. Lipoprotein (a) and comprehensive lipid tetrad index as a marker for coronary artery disease in NIDDM patients in South India. Clin Chim Acta 2006;372:70–5. https://doi.org/10.1016/j.cca.2006.03.019.Search in Google Scholar PubMed

20. Das, B, Daga, MK, Gupta, SK. Lipid Pentad Index: a novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India. Clin Biochem 2007;40:18–24. https://doi.org/10.1016/j.clinbiochem.2006.08.016.Search in Google Scholar PubMed

21. Singh, Y, Srivastava, S, Ahmad, S, Mishra, SK, Shirazi, N, Raja, M, et al.. Is lipid tetrad index the strongest predictor of premature coronary artery disease in North India. J Indian Acad Clin Med 2010;11:175–9.Search in Google Scholar

22. Ittermann, T, Baumeister, SE, Völzke, H, Wasner, C, Schminke, U, Wallaschofski, H, et al.. Are serum TSH levels associated with oxidized low‐density lipoprotein? Results from the Study of Health in Pomerania. Clin Endocrinol 2012;76:526–32. https://doi.org/10.1111/j.1365-2265.2011.04186.x.Search in Google Scholar PubMed

23. Bansal, SK, Agarwal, S, Daga, MK. Conventional and advanced lipid parameters in premature coronary artery disease patients in India. J Clin Diagn Res: J Clin Diagn Res 2015;9:BC07. https://doi.org/10.7860/JCDR/2015/14818.6844.Search in Google Scholar PubMed PubMed Central

24. Shyam, M. Lipid tetrad index: a new risk calculator for ST-elevation myocardial infarction. Madurai: Doctoral dissertation, Tamil Nadu Dr M.G.R. Medical University; 2019.Search in Google Scholar

25. Tarik, M, Chandra, S. To study the pattern of dyslipidemia in hypothyroid patients. J Medical Biomed Sci 2020;4:115–7. https://doi.org/10.32553/ijmbs.v4i1.877.Search in Google Scholar

26. Tzotzas, T, Krassas, GE, Konstantinidis, T, Bougoulia, M. Changes in lipoprotein (a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 2000;10:803–8. https://doi.org/10.1089/thy.2000.10.803.Search in Google Scholar PubMed

27. Lampka, M, Junik, R, Nowicka, A, Kardymowicz, H, Kaczorowski, P, Tyrakowski, T. Evaluation of low density lipoprotein oxidation in a course of hypothyroidism. Endokrynol Pol 2006;57:116–21.Search in Google Scholar

28. Verhoye, E, Langlois, MR. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med 2009;47:128–37. https://doi.org/10.1515/CCLM.2009.037.Search in Google Scholar PubMed

29. Bansal, SK, Agarwal, S, Daga, MK. Advanced atherogenic index for the assessment of consolidated lipid risk in premature coronary artery disease patients in India. J Lab Phys 2016;8:77. https://doi.org/10.4103/0974-2727.180786.Search in Google Scholar PubMed PubMed Central

30. Bansal, SK, Yadav, R. A study of the extended lipid profile including oxidized LDL, small dense LDL, lipoprotein (a) and apolipoproteins in the assessment of cardiovascular risk in hypothyroid patients. J Clin Diagn Res: JCDR. 2016;10:BC04–08. https://doi.org/10.7860/JCDR/2016/19775.8067.Search in Google Scholar PubMed PubMed Central

31. Morais, CA, Oliveira, SH, Lima, LM. Lipid tetrad index (LTI) and lipid pentad index (LPI) in healthy subjects. Arq Bras Cardiol 2013;100:322–7. https://doi.org/10.5935/abc.20130048.Search in Google Scholar

Received: 2022-02-10
Accepted: 2022-07-20
Published Online: 2022-09-01

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Thyrotropin and body mass index, are they related?
  4. Does dexamethasone inhibit glucose oxidase: an analysis in kinetics and molecular study
  5. Gene polymorphism of leptin and risk for heart disease, obesity, and high BMI: a systematic review and pooled analysis in adult obese subjects
  6. Decrease in serum asprosin levels following six weeks of spinning and stationary cycling training in overweight women
  7. Anti-proliferation effects of Apatinib in combination with Curcumin in breast cancer cells
  8. Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients
  9. Association of neutrophil gelatinase associated lipocalin, ischemia modified albumin with uric acid in the etiopathogenesis of preeclampsia
  10. Influence of eight weeks of combined training on adipsin and lipoprotein profile and possible relations with depression, anxiety and stress in women with multiple sclerosis
  11. The effect of the ratio of serum progesterone level to oocyte count on the day of IVF-ICSI injection on pregnancy outcomes in HCG cycles
  12. Level of non-conventional lipid parameters and its comparative analysis with TSH in subclinical hypothyroidism
  13. Case Report
  14. Long-term complete remission of metastatic adrenocortical carcinoma
  15. Minireview
  16. Omicron variant of SARS-CoV-2: a review of existing literature
  17. Review Articles
  18. Modulatory role of prolactin in type 1 diabetes
  19. Omicron variant in COVID-19 current pandemic: a reason for apprehension
  20. COVID-19: a viewpoint from hepatic perspective
  21. Potential role of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome
Downloaded on 23.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2022-0019/html
Scroll to top button